Recently, Galluci et al. studied the anti-inflammatory mechanism of fenofibrate by inhibiting NF-kappa B signaling in human macrophages and clinical outcomes in patients with PBC and MCP-1 [43]. Here, CCL2 is linked to primary biliary cholangitis.